Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Sex differences in elite track and field performances and inferences about steroid doping

View ORCID ProfileDiana B. Collantes, View ORCID ProfileJonathon W. Senefeld, View ORCID ProfileKathryn F. Larson, Doriane Lambelet Coleman, View ORCID ProfileMichael J. Joyner, View ORCID ProfileShalaya Kipp
doi: https://doi.org/10.1101/2024.05.23.24307812
Diana B. Collantes
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Diana B. Collantes
Jonathon W. Senefeld
2Department of Health and Kinesiology, University of Illinois Urbana-Champaign, Urbana, Illinois
3Beckman Institute for Advanced Science and Technology, University of Illinois Urbana-Champaign, Urbana, Illinois
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathon W. Senefeld
Kathryn F. Larson
4Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kathryn F. Larson
Doriane Lambelet Coleman
5Duke University School of Law, Durham, North Carolina
JD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Joyner
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota
6Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael J. Joyner
Shalaya Kipp
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shalaya Kipp
  • For correspondence: kipp.shalaya{at}mayo.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Females likely experience larger performance benefits from androgenic-anabolic steroids than males. We set out to determine if there were temporal differences in select athletics (track and field) records between females and males. Exploratory aims included: 1) evaluating the improvements in female and male world records over time, and 2) investigating the influence of doping programs on male and female world records before and after 1990 when sport’s governing bodies began to implement random out-of-competition and systematic in-competition drug testing. We collected the top 500 performances of all time for both sexes from an online database (worldathletics.org) in four running events (100m, 200m, 400m, and 800m) and two throwing events (discus throw and shot put). Data were stratified into quintiles based on world record ranking (1st to 100th, 101st to 200th, etc.). The temporal distribution of top 100 female performers was significantly earlier than top 100 male performers (year: 2000±1 vs 2005±1, respectively; p<0.001). Within event, the top performances occurred significantly earlier for females in the 800m (year: 1995±15 vs 2003±12; p<0.001) and shot put (year: 1992±14 vs 2003±17; p<0.001). Among females, world records rapidly improved through the 1980s, however following the 1990, the world records ceased to improve. Geographically, there was a greater representation of countries with state-sponsored doping programs, specifically among female performances. We postulate these sex differences in the temporal distribution of top performances are likely associated with enhanced effectiveness of exogenous androgens (steroid doping) among female athletes with lower endogenous androgen hormones compared to males.

What is the central question of this study?Despite a longstanding notion that top performance in athletics occurred earlier for females compared to males, likely due to the larger performance benefits of androgenic-anabolic steroids, no study has compared this temporal relation. Thus, we examined the temporal distribution of select athletics events between females and males.

What is the main finding and its importance?The top-100 female performances occurred earlier than the top-100 male performances. The sex-related temporal differences were particularly notable for the shot put and 800m. Furthermore, there was a greater representation of countries with known state-sponsored doping programs, specifically among females. Our analyses suggest anabolic-androgenic steroids played a greater role in the world’s best female athletics performances.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors declare no funding was received for this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability Statement

The analyzed datasets supporting this study are publicly available online at the World Athletics website. Supporting data are available upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 24, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Sex differences in elite track and field performances and inferences about steroid doping
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Sex differences in elite track and field performances and inferences about steroid doping
Diana B. Collantes, Jonathon W. Senefeld, Kathryn F. Larson, Doriane Lambelet Coleman, Michael J. Joyner, Shalaya Kipp
medRxiv 2024.05.23.24307812; doi: https://doi.org/10.1101/2024.05.23.24307812
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Sex differences in elite track and field performances and inferences about steroid doping
Diana B. Collantes, Jonathon W. Senefeld, Kathryn F. Larson, Doriane Lambelet Coleman, Michael J. Joyner, Shalaya Kipp
medRxiv 2024.05.23.24307812; doi: https://doi.org/10.1101/2024.05.23.24307812

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Endocrinology (including Diabetes Mellitus and Metabolic Disease)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)